ClinicalTrials.gg
Drug

Cangrelor clinical trials

Also written Kengreal and Kengrexal.

studies test it
26
open now
3
in phase 3
3
first study started
2005

How each study uses cangrelor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the cangrelor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Jun 2015 · KENGREAL · NDA 204958 (FDA, Drugs@FDA)
European Union
23 Mar 2015 · Kengrexal · EMEA/H/C/003773 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cangrelor
21
Cangrelor 50 MG
2

Brand

Kengreal
6
Kengrexal
2
Kengrexal 50 mg
1

Studies by the year they started

26 studies that test it; most in 2017 (7)

Studies that test cangrelor, by start year
YearStudies
20051
20062
20071
20082
20132
20161
20177
20182
20192
20212
20221
20231
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
7
Phase 3
3
Phase 4
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 18

The Medicines Company (7) · University of Florida (4) · The Royal Wolverhampton Hospitals NHS Trust (1) · Faculty Hospital Kralovske Vinohrady (1) · Chiesi Farmaceutici S.p.A. (1) · University Medical Centre Ljubljana (1) · Insel Gruppe AG, University Hospital Bern (1) · Icahn School of Medicine at Mount Sinai (1)

Often tested with

Tested in the same studies.

Ticagrelor (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test cangrelor.

Studies

Open first, then newest update. How each study uses cangrelor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test cangrelor →

Given beside what is tested · 1 — cangrelor is usual care or a partner of the new treatment

Codes

What other systems call cangrelor · ClinicalTrials.gg INT004134

  • MeSH (NLM) C117446cangrelorConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6AQ1Y404U7CANGRELORConfirmed FDA, NLM, Wikidata
  • RxNorm 1656052Confirmed FDA, Wikidata
  • Wikidata Q3655338cangrelorConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C76395CangrelorOne source FDA
  • DrugBank DB06441One source Wikidata

Also registered as cangrelor tetrasodium (UNII 2144G00Y7W · RxNorm 1656051).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.